Patent ID: 11926669
Assignee: HANALL BIOPHARMA CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An anti-FcRn antibody or an antigen binding fragment thereof comprising:
a light chain variable region comprising LCDR1 comprising the amino acid sequence of SEQ ID NO: 9, LCDR2 comprising the amino acid sequence of SEQ ID NO: 2, and LCDR3 comprising the amino acid sequence of SEQ ID NO: 3; and
a heavy chain variable region comprising HCDR1 comprising the amino acid sequence of SEQ ID NO: 11, HCDR2 comprising the amino acid sequence of SEQ ID NO: 6, and HCDR3 comprising the amino acid sequence of SEQ ID NO: 7.